Psychiatr. praxi. 2021;22(2):80-83 | DOI: 10.36290/psy.2021.016

Inflammation and psychotic disorders

MUDr. Kryštof Kantor, prof. MUDr. Klára Látalová, Ph.D.
Klinika psychiatrie FN a LF UP Olomouc

Inflammation is part of immune reaction to external and internal stimuli, particularly infectious insults. In recent years, the attention of experts has shifted from acute inflammatory response to mild chronic systemic inflammation. This phenomenon appears to play a role in the etiopathogenesis of many chronic diseases, such as cardiovascular disease, diabetes and obesity. In psychiatry, connection between inflammation and psychotic disorders is one of the major study interests. There is multiple evidence, that inflammation plays a role in a certain group of patients with psychosis. Markers that can help recognize this state in both acute and chronic psychotic disorders have been identified. A specific phenotype of schizophrenia spectrum disorders in which inflammation plays a significant role is being recognized. Research leads to theories of inflammation being one of the factors in the neurodevelopmental hypothesis of schizophrenia. This article introduces theoretical and research backgrounds to the connection between psychotic diseases and the immune system and presents an insight into attempts at the practical implementation of this knowledge into clinical practice.

Keywords: psychosis, schizophrenia, inflammation, immune system.

Published: July 9, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kantor K, Látalová K. Inflammation and psychotic disorders. Psychiatr. praxi. 2021;22(2):80-83. doi: 10.36290/psy.2021.016.
Download citation

References

  1. Müller N. Inflammation in Schizophrenia: Pathogenetic Aspects and Therapeutic Considerations. Schizophr Bull. 2018; 44(5): 973-982. Go to original source... Go to PubMed...
  2. Lee CH, Giuliani F. The Role of Inflammation in Depression and Fatigue. Front Immunol. 2019; 10: 1696. Go to original source... Go to PubMed...
  3. Köhler-Forsberg O, Müller N, Lennox BR. Editorial: The Role of Inflammation in the Etiology and Treatment of Schizophrenia. Front Psychiatry. 2020; 11: 603296. Go to original source... Go to PubMed...
  4. Shakhar K. The Inclusive Behavioral Immune System. Front Psychol. 2019; 10: 1004. Go to original source... Go to PubMed...
  5. Schaller M, Miller GE, Gervais WM, Yager S, Chen E. Mere visual perception of other people's disease symptoms facilitates a more aggressive immune response. Psychol Sci. 2010; 21(5): 649-652. Go to original source... Go to PubMed...
  6. Mortensen CR, Becker DV, Ackerman JM, Neuberg SL, Kenrick DT. Infection breeds reticence: the effects of disease salience on self-perceptions of personality and behavioral avoidance tendencies. Psychol Sci. 2010; 21(3): 440-447. Go to original source... Go to PubMed...
  7. Huang JY, Sedlovskaya A, Ackerman JM, Bargh JA. Immunizing against prejudice: effects of disease protection on attitudes toward out-groups. Psychol Sci. 2011; 22(12): 1550-1556. Go to original source... Go to PubMed...
  8. Schwambergová D et al. Role behaviorálního imunitního systému v obraně proti infekcím. Čes a slov Psychiatr 2020; 116(5): 234-242.
  9. Schaller, M. Parasites, Behavioral Defenses, and the Social Psychological Mechanisms through Which Cultures Are Evoked. Psychological Inquiry. 2016; 17(2): 96-101.
  10. Leonard BE, Schwarz M, Myint AM. The metabolic syndrome in schizophrenia: is inflammation a contributing cause? J Psychopharmacol. 2012; 26(5 Suppl): 33-41. Go to original source... Go to PubMed...
  11. Eaton WW, Byrne M, Ewald H, Mors O, Chen CY, Agerbo E, Mortensen PB. Association of schizophrenia and autoimmune diseases: linkage of Danish national registers. Am J Psychiatry. 2006; 163(3): 521-528. Go to original source... Go to PubMed...
  12. Köhler O, Petersen L, Mors O, Mortensen PB, Yolken RH, Gasse C, Benros ME. Infections and exposure to anti-infective agents and the risk of severe mental disorders: a nationwide study. Acta Psychiatr Scand. 2017; 135(2): 97-105. Go to original source... Go to PubMed...
  13. Leboyer M, Oliveira J, Tamouza R, Groc L. Is it time for immunopsychiatry in psychotic disorders? Psychopharmacology (Berl). 2016; 233(9): 1651-1660. Go to original source... Go to PubMed...
  14. Kępińska AP, Iyegbe CO, Vernon AC, Yolken R, Murray RM, Pollak TA. Schizophrenia and Influenza at the Centenary of the 1918-1919 Spanish Influenza Pandemic: Mechanisms of Psychosis Risk. Front Psychiatry. 2020; 11: 72. Go to original source... Go to PubMed...
  15. Gejman PV, Sanders AR, Kendler KS. Genetics of schizophrenia: new findings and challenges. Annu Rev Genomics Hum Genet. 2011; 12: 121-144. Go to original source... Go to PubMed...
  16. Goldsmith DR, Rapaport MH, Miller BJ. A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Mol Psychiatry. 2016; 21(12): 1696-1709. Go to original source... Go to PubMed...
  17. Orlovska-Waast S, Köhler-Forsberg O, Brix SW, Nordentoft M, Kondziella D, Krogh J, Benros ME. Cerebrospinal fluid markers of inflammation and infections in schizophrenia and affective disorders: a systematic review and meta-analysis. Mol Psychiatry. 2019; 24(6): 869-887. Erratum in: Mol Psychiatry. 2019 Mar 12. Go to original source... Go to PubMed...
  18. Fond G, Lançon C, Korchia T, Auquier P, Boyer L. The Role of Inflammation in the Treatment of Schizophrenia. Front Psychiatry. 2020; 11: 160. Go to original source... Go to PubMed...
  19. Black C, Miller BJ. Meta-Analysis of Cytokines and Chemokines in Suicidality: Distinguishing Suicidal Versus Nonsuicidal Patients. Biol Psychiatry. 2015; 78(1): 28-37. Go to original source... Go to PubMed...
  20. Coelho R, Viola TW, Walss-Bass C, Brietzke E, Grassi-Oliveira R. Childhood maltreatment and inflammatory markers: a systematic review. Acta Psychiatr Scand. 2014; 129(3): 180-192. Go to original source... Go to PubMed...
  21. Kirkpatrick B, Miller BJ. Inflammation and schizophrenia. Schizophr Bull. 2013; 39(6): 1174-1179. Go to original source... Go to PubMed...
  22. Pollak TA, Lennox BR, Müller S, Benros ME, Prüss H, Tebartz van Elst L, Klein H, Steiner J, Frodl T, Bogerts B, Tian L, Groc L, Hasan A, Baune BT, Endres D, Haroon E, Yolken R, Benedetti F, Halaris A, Meyer JH, Stassen H, Leboyer M, Fuchs D, Otto M, Brown DA, Vincent A, Najjar S, Bechter K. Autoimmune psychosis: an international consensus on an approach to the diagnosis and management of psychosis of suspected autoimmune origin. Lancet Psychiatry. 2020; 7(1): 93-108. Go to original source... Go to PubMed...
  23. Cho M, Lee TY, Kwak YB, Yoon YB, Kim M, Kwon JS. Adjunctive use of anti-inflammatory drugs for schizophrenia: A meta-analytic investigation of randomized controlled trials. Aust N Z J Psychiatry 2019; 53(8): 742-759. Go to original source... Go to PubMed...
  24. Zheng W, Cai DB, Yang XH, Ungvari GS, Ng CH, Müller N, Ning YP, Xiang YT. Adjunctive celecoxib for schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials. J Psychiatr Res. 2017; 92: 139-146. Go to original source... Go to PubMed...




Psychiatry for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.